MDGN- Finally moving after $4.10 offering two weeks ago, huge insider buying at that price, and today's news: Piper Jaffray initiates coverage on Medgenics (NYSE: MDGN) with an Overweight rating and a price target of $7.00.
Very large position here.
All that is needed to make a happy life is within yourself, in your way of thinking. -Marcus Aurelius